Hello Avatar! Welcome to another week of biotech analysis. Today’s commentary is as always on Thursday focused on the general market update. For the week XBI was UP +3% and remains green at +15% for the year. Today, we will dive into VC activity for Q2 2024. Venture capital funding surged to its highest point since Q2 2022, reaching $9.2B across 215 …
Keep reading with a 7-day free trial
Subscribe to BowTiedBiotech to keep reading this post and get 7 days of free access to the full post archives.